5-methyltryptamine has been researched along with naratriptan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adham, N; Audia, JE; Kohlman, DT; Krushinski, J; Liang, SX; Schaus, JM; Walker, C; Xu, YC; Zgombick, JM | 1 |
1 other study(ies) available for 5-methyltryptamine and naratriptan
| Article | Year |
|---|---|
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
Topics: Cell Line; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Radioligand Assay; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship; Tryptamines | 1999 |